Cell line development and synbio workflows driven by automation

Lori Euler and Chris Saenz from Beckman Coulter Life Sciences unveil strategies to elevate efficiency in synthetic biology workflows through automation, offering practical approaches to streamline processes and optimize productivity. In the second half of this SLAS 2024 presentation, Brian Murphy and Peter Braun, also of Beckman Coulter Life Sciences, offer valuable insights into refining the cell line development processes using automated antibody analytics on the Biomek i5 Liquid Handler. Don't miss this opportunity to learn from industry leaders about the transformative impact of automation and advanced analytics on cell line development, tackling bottlenecks, and accelerating drug development timelines.

This video was filmed at SLAS2024.